Technology Platform

miRecule’s DREAmiR™ platform integrates genomic sequencing, expression, and prognostic data from hundreds of  patients with high throughput screening data of RNA lead candidates. This process allows us to identify the best RNA candidates for therapy, modify them to improve their therapeutic profile, and formulate them into tissue targeted drug therapies.